OpenCompanies

Summit (Oxford) Limited

Company number
04636431
Status
Active
Type
Private Limited Company
Incorporated
14 Jan 2003
Nature of business
Research and experimental development on biotechnology
Corporate group
Summit Therapeutics Limited (2 companies)

Registered office

136a Eastern Avenue
Milton Park
Abingdon
OX14 4SB

Previous names

  • Vastox Chemical Genomics Limited (until 6 Aug 2007)
  • Vastox Limited (until 30 Sep 2004)

Officers

NameRoleAppointedResigned
WCPHD DIRECTORS LIMITED Corporate-Director 14 Jan 2003 17 Feb 2003
HALE AND DORR SECRETARIES LIMITED Corporate-Secretary 14 Jan 2003 8 Mar 2004
MONTGOMERY, John Alexander Secretary 8 Mar 2004 6 Jun 2005
MULVANEY, Andrew William, Dr Director 17 Feb 2003 7 Oct 2005
MONTGOMERY, John Alexander Director 17 Feb 2003 26 Sep 2006
TAYLOR, James Christopher Director 9 Aug 2006 31 Jan 2008
NORWOOD, David Robert Director 17 Feb 2003 31 Jan 2008
MILLINGTON, Darren Michael Director 9 May 2006 19 Sep 2008
MILLINGTON, Darren Michael Secretary 6 Jun 2005 19 Sep 2008
BENNING PRINCE, Sharon Jeen Secretary 19 Sep 2008 17 Nov 2008
WEIR, Anthony Director 17 Nov 2008 23 Mar 2009
WEIR, Anthony Secretary 17 Nov 2008 23 Mar 2009
LEE, Steven Koon Ching, Dr Director 28 Apr 2003 3 Dec 2010
PRICE, Barry John, Dr Director 18 Jan 2011 4 Apr 2012
STORER, Richard, Dr Director 26 Apr 2006 21 Nov 2012
DAVIES, Stephen Graham, Professor Director 17 Feb 2003 28 Feb 2013
STEFANOV, Ventzislav Kirilov, Dr Director 5 Jun 2020 5 Jun 2020
DUGGAN, Robert William Director 5 Jun 2020 5 Jun 2020
EDWARDS, Glyn Owain Director 4 Apr 2012 5 Jun 2020
STRANGE, Melissa Claire Secretary 17 Oct 2016 30 Jun 2020
STEFANOV, Ventzislav Kirilov, Dr Director 27 May 2020 4 Dec 2020
O'NEILL, Hugh Feargal Secretary 30 Jun 2020 8 Jun 2021
POWELL, David Jonathan, Dr. Director 29 Jan 2021 26 Nov 2021
MARANIAN, Jeffrey Director 6 Dec 2021 21 Jan 2022
HAIR, Campbell Director 6 Dec 2021 10 Aug 2022
DHINGRA, Ankur Director 18 Aug 2022 2 Apr 2024
ANAND, Bhaskar Director 17 Apr 2024
SONI, Manmeet Singh Director 6 Dec 2023
DUGGAN, Robert William Director 27 May 2020

Control

NameNature of controlNotifiedCeased
Summit Therapeutics Limited Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors
6 Apr 2016

Accounts

Connections

Owned by

Summit (Oxford) Limited → Summit Therapeutics Limited

Companies at the same address

Data